{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:09:37Z","timestamp":1790932177180,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R41EY031625-01S1"],"award-info":[{"award-number":["R41EY031625-01S1"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41EY033262-01"],"award-info":[{"award-number":["R41EY033262-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ymthe.2024.09.007","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T17:48:09Z","timestamp":1725731289000},"page":"4006-4020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex\u00a0vivo gene therapy"],"prefix":"10.1016","volume":"32","author":[{"given":"Brian C.","family":"Gilger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5539-0099","authenticated-orcid":false,"given":"Tomoko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Bryan","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn J.","family":"Bower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2062-0744","authenticated-orcid":false,"given":"Matthew L.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.09.007_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ophtha.2023.03.012","article-title":"Global Trends in Blindness and Vision Impairment Resulting from Corneal Opacity 1984-2020: A Meta-analysis","volume":"130","author":"Wang","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2024.09.007_bib2","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ymthe.2024.09.007_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ophtha.2020.06.042","article-title":"In Pursuit of the Elimination of Corneal Blindness: Is Establishing Eye Banks and Training Surgeons Enough?","volume":"128","author":"Jeng","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2024.09.007_bib4","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ymthe.2024.09.007_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001605","article-title":"Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis","volume":"11","author":"Stocks","year":"2014","journal-title":"PLoS Med."},{"key":"10.1016\/j.ymthe.2024.09.007_bib6","article-title":"Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age","volume":"3","author":"Imdad","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymthe.2024.09.007_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global Survey of Corneal Transplantation and Eye Banking","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib8","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.4049\/jimmunol.1600251","article-title":"Alloimmunity and Tolerance in Corneal Transplantation","volume":"196","author":"Amouzegar","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/ajt.13926","article-title":"The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure","volume":"17","author":"Hopkinson","year":"2017","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ymthe.2024.09.007_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1034\/j.1600-0420.2001.790308.x","article-title":"Risk factors for corneal graft failure and rejection in penetrating keratoplasty","volume":"79","author":"Inoue","year":"2001","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.ymthe.2024.09.007_bib11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ajo.2005.07.024","article-title":"The impact of corneal allograft rejection on the long-term outcome of corneal transplantation","volume":"140","author":"Coster","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/2008-322X.200156","article-title":"Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation","volume":"12","author":"Abud","year":"2017","journal-title":"J.\u00a0Ophthalmic Vis. Res."},{"key":"10.1016\/j.ymthe.2024.09.007_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/01.ico.0000153103.27399.e6","article-title":"A risk score as part of an evidence-based approach to the selection of corneal replacement surgery","volume":"24","author":"Hicks","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.ymthe.2024.09.007_bib14","first-page":"2485","article-title":"Loss and restoration of immune privilege in eyes with corneal neovascularization","volume":"37","author":"Dana","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.007_bib15","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1097\/TP.0000000000002938","article-title":"High-risk\u00a0Corneal Transplantation: Recent Developments and Future Possibilities","volume":"103","author":"Armitage","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2024.09.007_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ajo.2015.06.012","article-title":"Transplant rejection following endothelial keratoplasty and penetrating keratoplasty in the United Kingdom: incidence and survival","volume":"160","author":"Figueiredo","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archopht.1981.03930010599002","article-title":"Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment","volume":"99","author":"Alldredge","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib18","series-title":"Corneal Graft Rejection","author":"Gurnani","year":"2023"},{"key":"10.1016\/j.ymthe.2024.09.007_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.TP.0000147196.79546.69","article-title":"CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis","volume":"79","author":"Hegde","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2024.09.007_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.06.011","article-title":"The eye: A window to the soul of the immune system","volume":"45","author":"Perez","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.ymthe.2024.09.007_bib21","article-title":"Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty","volume":"2015","author":"Abudou","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymthe.2024.09.007_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.ico.0000178731.42187.46","article-title":"Prevention and treatment of corneal graft rejection: current practice patterns (2004)","volume":"25","author":"Randleman","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.ymthe.2024.09.007_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10792-007-9100-7","article-title":"Pharmacologic strategies in the prevention and treatment of corneal transplant rejection","volume":"28","author":"Tabbara","year":"2008","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0021-5155(99)00223-3","article-title":"Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty","volume":"44","author":"Inoue","year":"2000","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.ICL.0000062460.03555.32","article-title":"Topical cyclosporine in pediatric keratoplasty","volume":"29","author":"Cosar","year":"2003","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ymthe.2024.09.007_bib26","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.ophtha.2006.05.022","article-title":"Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes","volume":"113","author":"Price","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2024.09.007_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: An Immune Checkpoint Molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.humimm.2017.04.007","article-title":"Expression and differential regulation of HLA-G isoforms in the retinal pigment epithelial cell line, ARPE-19","volume":"78","author":"Svendsen","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","article-title":"Expression of HLA-G in human cornea, an immune-privileged tissue","volume":"64","author":"Le Discorde","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1067\/mob.2000.106762","article-title":"Soluble HLA-G circulates in maternal blood during pregnancy","volume":"183","author":"Hunt","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib31","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1073\/pnas.89.9.3947","article-title":"Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens","volume":"89","author":"Ishitani","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.09.007_bib32","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1182\/blood-2005-12-019919","article-title":"Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells","volume":"108","author":"Fons","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.007_bib33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.189.7.1093","article-title":"A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells","volume":"189","author":"Rajagopalan","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.09.007_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/1074-7613(95)90130-2","article-title":"The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association","volume":"3","author":"Lee","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.09.007_bib35","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4049\/jimmunol.171.3.1343","article-title":"Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function","volume":"171","author":"Gonen-Gross","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0960-9822(02)00481-5","article-title":"Nonclassical HLA-G molecules are classical peptide presenters","volume":"6","author":"Diehl","year":"1996","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib37","doi-asserted-by":"crossref","first-page":"16180","DOI":"10.1073\/pnas.212643199","article-title":"Disulfide bond-mediated dimerization of HLA-G on the cell surface","volume":"99","author":"Boyson","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.09.007_bib38","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1074\/jbc.M512305200","article-title":"Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer","volume":"281","author":"Shiroishi","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.09.007_bib39","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1073\/pnas.0803341105","article-title":"Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway","volume":"105","author":"Liang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.09.007_bib40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.humimm.2012.11.060","article-title":"The long-term immunosuppressive effects of disulfide-linked HLA-G dimer in mice with collagen-induced arthritis","volume":"74","author":"Kuroki","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib41","article-title":"HLA-G dimers in the prolongation of kidney allograft survival","volume":"2014","author":"Ezeakile","year":"2014","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.ymthe.2024.09.007_bib42","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.3390\/ijms23073465","article-title":"Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye","volume":"23","author":"Gilger","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.09.007_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.omtm.2023.03.012","article-title":"AAV-mediated expression of HLA-G for the prevention of experimental ocular graft vs. host disease","volume":"29","author":"Nilles","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.007_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18002-9","article-title":"AAV vector-meditated expression of HLA-G reduces injury-induced corneal vascularization, immune cell infiltration, and fibrosis","volume":"7","author":"Hirsch","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.09.007_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56462-3","article-title":"AAV-mediated expression of HLA-G1\/5 reduces severity of experimental autoimmune uveitis","volume":"9","author":"Crabtree","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.09.007_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41434-018-0035-6","article-title":"Serotype survey of AAV gene delivery via subconjunctival injection in mice","volume":"25","author":"Song","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.007_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.yrtph.2017.03.013","article-title":"Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics","volume":"86","author":"de Zafra","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0952-7915(94)90081-7","article-title":"Cytokines and the Th1\/Th2 paradigm in transplantation","volume":"6","author":"Nickerson","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.trim.2009.03.006","article-title":"A pathogenic role of IL- 17 at the early stage of corneal allograft rejection","volume":"21","author":"Chen","year":"2009","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib50","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.09.007_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00018-010-0581-6","article-title":"HLA-G in organ transplantation: towards clinical applications","volume":"68","author":"Deschaseaux","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2024.09.007_bib52","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.tp.0000269117.32179.1c","article-title":"Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation","volume":"84","author":"Rouas-Freiss","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2024.09.007_bib53","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ymthe.2020.04.004","article-title":"Intrastromal Gene Therapy Prevents and Reverses Advanced Corneal Clouding in a Canine Model of Mucopolysaccharidosis I","volume":"28","author":"Miyadera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.09.007_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.omtm.2020.05.014","article-title":"Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits","volume":"18","author":"Song","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.007_bib55","first-page":"2614","article-title":"Role of CD4+ T\u00a0cells in immunobiology of orthotopic corneal transplants in mice","volume":"40","author":"Yamada","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.007_bib56","first-page":"2723","article-title":"Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody","volume":"32","author":"He","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.007_bib57","article-title":"Corneal Allograft Rejection: Immunopathogenesis to Therapeutics","volume":"2013","author":"Qazi","year":"2013","journal-title":"J.\u00a0Clin. Cel Immunol"},{"key":"10.1016\/j.ymthe.2024.09.007_bib58","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/ajt.16968","article-title":"Enhanced autophagy alleviated corneal allograft rejection via inhibiting NLRP3 inflammasome activity","volume":"22","author":"Wei","year":"2022","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ymthe.2024.09.007_bib59","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/nprot.2006.207","article-title":"Production and characterization of adeno-associated viral vectors","volume":"1","author":"Grieger","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2024.09.007_bib60","first-page":"51159","article-title":"An alkali-burn injury model of corneal neovascularization in the mouse","volume":"86","author":"Anderson","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2024.09.007_bib61","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1167\/iovs.05-1425","article-title":"Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits","volume":"47","author":"Shi","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.007_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/IR:25:1:01","article-title":"Experimental corneal allograft rejection","volume":"25","author":"Gebhardt","year":"2002","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ymthe.2024.09.007_bib63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1463-5224.2002.00243.x","article-title":"Veterinary ophthalmology in laboratory animal studies","volume":"5","author":"Munger","year":"2002","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.007_bib64","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1369\/0022155411418115","article-title":"Localization of a wide-ranging panel of antigens in the rat retina by immunohistochemistry: comparison of Davidson's solution and formalin as fixatives","volume":"59","author":"Chidlow","year":"2011","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.ymthe.2024.09.007_bib65","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1167\/iovs.09-5107","article-title":"Kinetics of immune cell infiltration in vaccinia virus keratitis","volume":"51","author":"Altmann","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.007_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119906","article-title":"Membrane fusion FerA domains enhance adeno-associated virus vector transduction","volume":"241","author":"Zhang","year":"2020","journal-title":"Biomaterials"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:28:29Z","timestamp":1783020509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624005951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1525001624005951"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.007","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex\u00a0vivo gene therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}